KALAN KELCH: Open Payments
NPI 1659764124 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 49 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $620 · 2025 $786
Food & beverage: $786
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 12 | $178 |
| Collegium Pharmaceutical, Inc. | 16 | $144 |
| Medtronic, Inc. | 5 | $99 |
| Boston Scientific Corporation | 2 | $88 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $68 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $48 |
| Valinor Pharma, LLC | 3 | $47 |
| Saluda Medical Americas, Inc. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| ImpactOrtho, Inc. | 1 | $22 |
Products named: OCTRODE, Belbuca, General - Pain Management, RELISTOR, KYPHON EXPRESS II KYPHOPAK TRAY, JOURNAVX, MOVANTIK, ETERNA.
Industry payments across AZ — which companies pay providers there.
